FDA.reportPublic FDA data

Application 205130

Type
ANDA
Sponsor
SCIEGEN PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEVETIRACETAMLEVETIRACETAMTABLET, EXTENDED RELEASE;ORAL500MGNoNo
002LEVETIRACETAMLEVETIRACETAMTABLET, EXTENDED RELEASE;ORAL750MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50228-189LevetiracetamlevetiracetamScieGen Pharmaceuticals, IncANDACurrent
50228-189LevetiracetamlevetiracetamScieGen Pharmaceuticals, IncANDACurrent
50228-190LevetiracetamlevetiracetamScieGen Pharmaceuticals, IncANDACurrent
50228-190LevetiracetamlevetiracetamScieGen Pharmaceuticals, IncANDACurrent
69367-332LevetiracetamLevetiracetamWestminster Pharmaceuticals, LLCANDACurrent
69367-333LevetiracetamLevetiracetamWestminster Pharmaceuticals, LLCANDACurrent
71205-728LevetiracetamLevetiracetamProficient Rx LPANDACurrent
71205-880LevetiracetamLevetiracetamProficient Rx LPANDACurrent
71205-880LevetiracetamLevetiracetamProficient Rx LPANDACurrent
71205-881LevetiracetamLevetiracetamProficient Rx LPANDACurrent
71205-881LevetiracetamLevetiracetamProficient Rx LPANDACurrent